Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-13

Clinical Trial Update: Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

View source ↗

Summary

This trial update discusses how the Atazanavir 150L mutation influences response to subsequent HIV treatments in HIV-infected subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Status: COMPLETED